14 | Proteins (Proteins, Gene)FDA Link
01/2023
-
10/2002 |
10 | ATP-Binding Cassette Transporters (ABC Transporters)IBA
07/2020
-
01/2016 |
8 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
07/2021
-
04/2011 |
6 | Adenosine Triphosphate (ATP)IBA
07/2020
-
01/2017 |
6 | Biomarkers (Surrogate Marker)IBA
01/2020
-
01/2013 |
5 | Doxorubicin (Adriamycin)FDA LinkGeneric
07/2021
-
05/2014 |
4 | Cisplatin (Platino)FDA LinkGeneric
12/2022
-
12/2013 |
4 | Paclitaxel (Taxol)FDA LinkGeneric
12/2022
-
01/2017 |
4 | Topotecan (Hycamtin)FDA LinkGeneric
01/2021
-
06/2014 |
4 | Antineoplastic Agents (Antineoplastics)IBA
07/2020
-
01/2018 |
3 | RNA (Ribonucleic Acid)IBA
01/2023
-
01/2022 |
3 | oridoninIBA
01/2020
-
01/2016 |
3 | ErbB Receptors (EGF Receptor)IBA
01/2019
-
01/2013 |
2 | AntigensIBA
03/2024
-
01/2023 |
2 | Chimeric Antigen ReceptorsIBA
03/2024
-
01/2023 |
2 | Phosphotransferases (Kinase)IBA
12/2022
-
01/2019 |
2 | EnzymesIBA
01/2022
-
11/2018 |
2 | venetoclaxIBA
01/2022
-
02/2020 |
2 | 9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2021
-
01/2020 |
2 | Member 2 Subfamily G ATP Binding Cassette TransporterIBA
01/2021
-
11/2020 |
2 | Tyrosine Kinase InhibitorsIBA
01/2020
-
01/2018 |
2 | Irinotecan (Camptosar)FDA LinkGeneric
01/2018
-
07/2017 |
2 | Messenger RNA (mRNA)IBA
05/2017
-
06/2004 |
2 | CholesterolIBA
09/2015
-
01/2013 |
2 | SterolsIBA
09/2015
-
01/2013 |
2 | Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
08/2012
-
04/2011 |
2 | Phosphodiesterase 5 InhibitorsIBA
08/2012
-
04/2011 |
2 | Single-Chain AntibodiesIBA
05/2010
-
01/2001 |
2 | Laminin (Merosin)IBA
10/2002
-
05/2002 |
2 | CollagenIBA
10/2002
-
05/2002 |
1 | Cyclin D1IBA
01/2023 |
1 | Circular RNAIBA
01/2023 |
1 | Mitochondrial RNAIBA
01/2023 |
1 | LipidsIBA
01/2023 |
1 | AllergensIBA
01/2023 |
1 | Macrophage Colony-Stimulating FactorIBA
12/2022 |
1 | Docetaxel (Taxotere)FDA Link
12/2022 |
1 | Taxoids (Taxanes)IBA
12/2022 |
1 | Interleukin-1 Receptor-Associated KinasesIBA
12/2022 |
1 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
12/2022 |
1 | Carboplatin (JM8)FDA LinkGeneric
12/2022 |
1 | Janus Kinase 2IBA
12/2022 |
1 | geniposideIBA
06/2022 |
1 | InflammasomesIBA
06/2022 |
1 | Fatty Acids (Saturated Fatty Acids)IBA
01/2022 |
1 | Amino AcidsFDA Link
01/2022 |
1 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 |
1 | Type I DNA Topoisomerases (Topoisomerase I)IBA
12/2021 |
1 | evodiamineIBA
12/2021 |
1 | CurcuminIBA
07/2021 |
1 | Phosphates (Orthophosphate)IBA
04/2021 |
1 | TubulinIBA
04/2021 |
1 | Proteolysis Targeting ChimeraIBA
01/2021 |
1 | Hypnotics and Sedatives (Sedatives)IBA
01/2021 |
1 | SurvivinIBA
01/2021 |
1 | Interleukin-10 (Interleukin 10)IBA
01/2021 |
1 | Tramadol (K315)FDA LinkGeneric
01/2021 |
1 | DexmedetomidineFDA Link
01/2021 |
1 | Tripartite Motif ProteinsIBA
01/2021 |
1 | p38 Mitogen-Activated Protein KinasesIBA
01/2021 |
1 | alectinibIBA
01/2021 |
1 | Therapeutic UsesIBA
01/2021 |